knowledge -WSS

knowledge

author：fashion 2025-09-06 03:17:35 - browse：2879

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Why sickle cell disease is getting the first CRISPR treatment

WSS

AI used to predict Covid

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Pfizer plans to depart BIO

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Biohaven protein

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pregnancy discrimination could be enabled by AI

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Akili, maker of video game for ADHD, to be acquired for 34 million

As demand for Covid shots wanes, Moderna seeks its next success

First Opinion Podcast: What happens when kids become caregivers?

Novavax promises a turnaround & Lilly roils the obesity market

Pregnancy discrimination could be enabled by AI

Heart attack and stroke risk calculators need revising

Health insurers say they are turning to AI to cut costs, improve care

entertainment

Average age of first period drops to 11.9 years, study shows

What will save rural psychiatry services? Higher Medicaid payments

What PEPFAR has meant on the ground in Ukraine

Pregnancy discrimination could be enabled by AI

Leukemia patients are helped by Syndax's new type of therapy

AI models in health care face new federal disclosure requirements

leisure time

knowledge

explore

focus